Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-03-07
1997-10-07
Leary, Louise
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514464, 514468, 514783, 514825, 514886, 514887, 514904, 514905, 4241951, 424DIG13, A01N 4304, A01N 4330, A01N 2500, A01N 6500
Patent
active
056748531
ABSTRACT:
The present invention features saponin containing enteral formulations for treatment of infection and inflammation. These saponin containing formulations are particularly useful in conjunction with oils rich in .omega.3 polyunsaturated fatty acids such as fish oils and flax oil but also show benefits with .omega.6 rich oils such as borage oil, black currant seed oil, canola oil and rapeseed oil. These formulations may also contain a lignan from the sesamin family.
REFERENCES:
patent: 3901875 (1975-08-01), Park
patent: 3920440 (1975-11-01), Takaoka et al.
patent: 4317816 (1982-03-01), Arichi et al.
patent: 4339442 (1982-07-01), Takemoto et al.
patent: 4375480 (1983-03-01), Soma
patent: 4427694 (1984-01-01), Benecke et al.
patent: 4442092 (1984-04-01), McBrayer
patent: 4501734 (1985-02-01), Tanaka et al.
patent: 4649206 (1987-03-01), Namiki et al.
patent: 4708820 (1987-11-01), Namiki et al.
patent: 4722941 (1988-02-01), Eckert et al.
patent: 4752618 (1988-06-01), Mascioli et al.
patent: 4755504 (1988-07-01), Liu
patent: 4767626 (1988-08-01), Cheng
patent: 4774229 (1988-09-01), Jordan
patent: 4774343 (1988-09-01), Namiki et al.
patent: 4780475 (1988-10-01), Cerra et al.
patent: 4803153 (1989-02-01), Shibata et al.
patent: 4810726 (1989-03-01), Bistrian et al.
patent: 4871768 (1989-10-01), Bistrian et al.
patent: 4920098 (1990-04-01), Cotter et al.
patent: 4966893 (1990-10-01), Pang et al.
patent: 4981844 (1991-01-01), Alexander et al.
patent: 5053387 (1991-10-01), Alexander
patent: 5055446 (1991-10-01), Alexander et al.
patent: 5166139 (1992-11-01), Bombardelli et al.
patent: 5180588 (1993-01-01), Shinmen et al.
patent: 5209826 (1993-05-01), Ozaki et al.
patent: 5211953 (1993-05-01), Shinmen et al.
patent: 5214062 (1993-05-01), Mark et al.
patent: 5229136 (1993-07-01), Mark et al.
patent: 5231085 (1993-07-01), Alexander et al.
patent: 5260336 (1993-11-01), Forse et al.
patent: 5270335 (1993-12-01), Akimoto et al.
patent: 5273965 (1993-12-01), Kensil et al.
patent: 5397778 (1995-03-01), Forse et al.
Baker et al., (1983), "Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model", Surgery, vol. Aug. 1983, pp. 331-335.
Fink et al., (1990), "Laboratory Models of Sepsis and Septic Shock", Journal of Surgical Research, vol. 49, pp. 186-196; month not available.
Hirose et al., (1991), "Inhibition of cholesterol absorption and synthesis in rats by sesamin", Journal of Lipid Research, vol. 32, pp. 629-638; month not available.
Newman et al., (1957), "Dietary Saponin, a Factor Which May Reduce Liver and Serum Cholesterol Levels", Poultry Science, vol. 37, pp. 42-45; month not available.
Salerno and Smith, (1991), "The Use of Sesame Oil and Other Vegetable Oils in the Inhibition of Human Colon Growth in Vitro", Anticancer Research, vol. 11, pp. 209-216; month not available.
Shimizu et al., (1989), "Production of Dihmo-.gamma.-linolenic Acid by Mortierella alpina 1S-4", JAOCS, vol. 66, No. 2, pp. 237-241; month not available.
Shimizu et al., (1991), "Sesamin Is a Potent and Specific Inhibitor of .increment.5 Desaturase in Polyunsaturated Fatty Acid biosynthesis", Lipids, vol. 26, No. 7, pp. 512-516; month not available.
Shimizu et al., (1993), "Studies on Desaturase Inhibitors of Polyunsaturated Fatty Acid Biosynthesis", A. Sinclair and R. Gibson (eds.), American Oil Chemists' Society, pp. 37-41; month not available.
Sugano and Akimoto, (1993), "Sesamin: A Multifunctional Gift From Natire", Journal of Chinese Nutrition Society, vol. 18, pp. 1-11; month not available.
Thibault and Richou (1936), C.R.Soc. Biol. (Societede Biologie), vol. 121, pp. 718-721 (English version not available) month not available.
Chavali, S.R. and Campbell, J.B., "Adjuvant Effects of Orally Administered Saponins on Humoral and Cellular Immune Responses in Mice," Immunobiol., vol. 174, pp. 347-359 (1987); month not available.
Chavali, S.R. and Campbell J.B., "Immunomodulatory Effects of Orally-Administered Saponins and Nonspecific Resistance Against Rabies Infection," Int. Archs. Allergy Appl. Immun., vol. 84, pp. 129-134 (1987); month not available.
Darias, V., et al., "Cytostatic and Antibacterial Activity of Some Compounds Isolated from Several Lamiaceae Species from the Canary Islands," Planta Medica, vol. 56, pp. 70-72 (1990); month not available.
Li-Jian, Y. and Run-Di, M., "Effects of Tubeimoside- 1 on HIV Core Protein p24 and Cytopathogenesis in Vitro," Acta Pharmacologica Sinica, vol. 15, No. 2, pp. 103-106 (1994). month not available;
Miller, C, et al., "Dietary Supplementation with Ethyl Ester Concentrates of Fish Oil (n-3) and Borage Oil (n-6) Polyunsaturated Fatty Acids Induces Epidermal Generation of Local Putative Anti-Inflammatory Metabolites," The Journal of Investigative Dermatology, vol. 96, pp. 98-103 (1991); month not available.
Mowat, A.M. et al, "Immune-Stimulating Complexes Containing Quil A and Protein Antigen Prime Class I MHC-Restricted T Lymphocytes in Vivo and are Immunogenic by the Oral Route," Immunology, vol. 72, pp. 317-322 (1991); month not available.
Segal, R., "The Protective Action of Glycyrrhizin Against Saponin Toxicity," Biochemical Pharmacology, vol. 26, No. 7, pp. 643-645 (1977) month not available.
Chavali Sambasiva
Forse R. Armour
Beth Israel Deaconess Medical Center Inc.
Leary Louise
LandOfFree
Enternal formulations for treatment of inflammation and infectio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enternal formulations for treatment of inflammation and infectio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enternal formulations for treatment of inflammation and infectio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2357454